Prabhakar, S., Cheah, P. S., Zhang, X., Zinter, M., Gianatasio, M., Hudry, E., . . . Breakefield, X. O. (2019). Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Mol Ther Methods Clin Dev.
Citação norma ChicagoPrabhakar, Shilpa, et al. "Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1." Mol Ther Methods Clin Dev 2019.
ציטוט MLAPrabhakar, Shilpa, et al. "Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1." Mol Ther Methods Clin Dev 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.